314 related articles for article (PubMed ID: 8909317)
1. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis.
Kuczyk MA; Serth J; Bokemeyer C; Jonassen J; Machtens S; Werner M; Jonas U
Cancer; 1996 Nov; 78(9):1958-66. PubMed ID: 8909317
[TBL] [Abstract][Full Text] [Related]
2. Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors.
Schenkman NS; Sesterhenn IA; Washington L; Tong YA; Weghorst CM; Buzard GS; Srivastava S; Moul JW
J Urol; 1995 Aug; 154(2 Pt 1):617-21. PubMed ID: 7609148
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the p53 oncoprotein in carcinoma in situ of the testis.
Kuczyk MA; Serth J; Bokemeyer C; Allhoff EP; Jonassen J; Kuczyk S; Jonas U
Pathol Res Pract; 1994 Nov; 190(11):993-8. PubMed ID: 7746746
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical and mutational analysis of the p53 tumour suppressor gene and the bcl-2 oncogene in primary testicular germ cell tumours.
Heidenreich A; Schenkman NS; Sesterhenn IA; Mostofi KF; Moul JW; Srivastava S; Engelmann UH
APMIS; 1998 Jan; 106(1):90-9; discussion 99-100. PubMed ID: 9524567
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors.
Heidenreich A; Gaddipati JP; Moul JW; Srivastava S
J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations and expression in breast carcinoma in situ.
Lukas J; Niu N; Press MF
Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: pathogenetic relevance.
Rajpert-De Meyts E; Kvist M; Skakkebaek NE
Virchows Arch; 1996 Jun; 428(3):133-9. PubMed ID: 8688967
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of P53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease.
Lewis DJ; Sesterhenn IA; McCarthy WF; Moul JW
J Urol; 1994 Aug; 152(2 Pt 1):418-23. PubMed ID: 8015085
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
10. High-resolution comparative genomic hybridization detects extra chromosome arm 12p material in most cases of carcinoma in situ adjacent to overt germ cell tumors, but not before the invasive tumor development.
Ottesen AM; Skakkebaek NE; Lundsteen C; Leffers H; Larsen J; Rajpert-De Meyts E
Genes Chromosomes Cancer; 2003 Oct; 38(2):117-25. PubMed ID: 12939739
[TBL] [Abstract][Full Text] [Related]
11. p53 mutation is infrequent in clear cell carcinoma of the ovary.
Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS
Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858
[TBL] [Abstract][Full Text] [Related]
12. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer.
Esrig D; Spruck CH; Nichols PW; Chaiwun B; Steven K; Groshen S; Chen SC; Skinner DG; Jones PA; Cote RJ
Am J Pathol; 1993 Nov; 143(5):1389-97. PubMed ID: 7901994
[TBL] [Abstract][Full Text] [Related]
13. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
Dahiya R; Deng G; Selph C; Carroll P; Presti J
Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
[TBL] [Abstract][Full Text] [Related]
14. Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours.
Hoei-Hansen CE; Almstrup K; Nielsen JE; Brask Sonne S; Graem N; Skakkebaek NE; Leffers H; Rajpert-De Meyts E
Histopathology; 2005 Jul; 47(1):48-56. PubMed ID: 15982323
[TBL] [Abstract][Full Text] [Related]
15. Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells.
Jørgensen N; Rajpert-De Meyts E; Graem N; Müller J; Giwercman A; Skakkebaek NE
Lab Invest; 1995 Feb; 72(2):223-31. PubMed ID: 7531795
[TBL] [Abstract][Full Text] [Related]
16. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
[TBL] [Abstract][Full Text] [Related]
17. Pagetoid spread of intratubular germ cell neoplasia into rete testis: a morphologic and histochemical study of 100 orchiectomy specimens with invasive germ cell tumors.
Perry A; Wiley EL; Albores-Saavedra J
Hum Pathol; 1994 Mar; 25(3):235-9. PubMed ID: 7512072
[TBL] [Abstract][Full Text] [Related]
18. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
20. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
